Blood test could spot cancer return months before scans
NCT ID NCT07382505
First seen Feb 02, 2026 · Last updated May 13, 2026 · Updated 16 times
Summary
This study will test a new blood test that looks for tiny bits of cancer DNA (called MRD) in 600 people with endometrial or cervical cancer. The goal is to see if this test can find cancer coming back earlier than current methods like CT scans. Participants will give blood samples at key times—before treatment, after surgery, and during follow-up—to help doctors learn if this test can guide personalized care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
Seoul, Seoul, 05505, South Korea
Conditions
Explore the condition pages connected to this study.